167 related articles for article (PubMed ID: 7849309)
1. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Uckun FM; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
Blood; 1995 Feb; 85(4):873-8. PubMed ID: 7849309
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
Uckun FM; Sather HN; Waurzyniak BJ; Sensel MG; Chelstrom L; Ek O; Sarquis MB; Nachman J; Bostrom B; Reaman GH; Gaynon PS
Leuk Lymphoma; 1998 Aug; 30(5-6):503-14. PubMed ID: 9711913
[TBL] [Abstract][Full Text] [Related]
3. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
4. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.
Yan Y; Salomon O; McGuirk J; Dennig D; Fernandez J; Jagiello C; Nguyen H; Collins N; Steinherz P; O'Reilly RJ
Blood; 1996 Oct; 88(8):3137-46. PubMed ID: 8874214
[TBL] [Abstract][Full Text] [Related]
5. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
Ramírez M; Díaz MA; Madero L; Bueren JA
Leuk Res; 2003 Dec; 27(12):1153-7. PubMed ID: 12921954
[TBL] [Abstract][Full Text] [Related]
7. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
8. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Uckun FM; Waurzyniak BJ; Sather HN; Sensel MG; Chelstrom L; Nachman J; Gaynon PS; Bostrom B; Ek O; Sarquis M; Steinherz PG; Reaman GH
Leuk Lymphoma; 1999 Feb; 32(5-6):475-87. PubMed ID: 10048420
[TBL] [Abstract][Full Text] [Related]
10. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
[TBL] [Abstract][Full Text] [Related]
11. Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
Uckun FM; Waurzyniak BJ; Sensel MG; Chelstrom L; Crotty ML; Gaynon PS; Reaman GH
Leuk Lymphoma; 1998 Jul; 30(3-4):269-77. PubMed ID: 9713959
[TBL] [Abstract][Full Text] [Related]
12. Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias.
Yan Y; Wieman EA; Guan X; Jakubowski AA; Steinherz PG; O'Reilly RJ
J Hematol Oncol; 2009 Dec; 2():51. PubMed ID: 20040095
[TBL] [Abstract][Full Text] [Related]
13. Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide.
Uckun FM; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Manivel C; Irvin JD; Myers DE; Gunther R
Blood; 1992 Jun; 79(12):3116-29. PubMed ID: 1375841
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
Yamada M; Wasserman R; Lange B; Reichard BA; Womer RB; Rovera G
N Engl J Med; 1990 Aug; 323(7):448-55. PubMed ID: 2095753
[TBL] [Abstract][Full Text] [Related]
15. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.
Steele JP; Clutterbuck RD; Powles RL; Mitchell PL; Horton C; Morilla R; Catovsky D; Millar JL
Blood; 1997 Sep; 90(5):2015-9. PubMed ID: 9292537
[TBL] [Abstract][Full Text] [Related]
16. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
17. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Steinherz PG; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
Blood; 1996 Dec; 88(11):4288-95. PubMed ID: 8943865
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice.
Kamel-Reid S; Letarte M; Doedens M; Greaves A; Murdoch B; Grunberger T; Lapidot T; Thorner P; Freedman MH; Phillips RA
Blood; 1991 Dec; 78(11):2973-81. PubMed ID: 1835412
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
20. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
Myers DE; Uckun FM
Leuk Lymphoma; 1995 Jun; 18(1-2):119-22. PubMed ID: 8580813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
